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Mapping axon initial segment structure and
function by multiplexed proximity biotinylation
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Donna J. Palmer2, Philip Ng2, Christophe Leterrier 3, Juan A. Oses-Prieto 4, Alma L. Burlingame4 &
Matthew N. Rasband 1*
Axon initial segments (AISs) generate action potentials and regulate the polarized distribu-
tion of proteins, lipids, and organelles in neurons. While the mechanisms of AIS Na+ and K+
channel clustering are understood, the molecular mechanisms that stabilize the AIS and
control neuronal polarity remain obscure. Here, we use proximity biotinylation and mass
spectrometry to identify the AIS proteome. We target the biotin-ligase BirA* to the AIS by
generating fusion proteins of BirA* with NF186, Ndel1, and Trim46; these chimeras map the
molecular organization of AIS intracellular membrane, cytosolic, and microtubule compart-
ments. Our experiments reveal a diverse set of biotinylated proteins not previously reported
at the AIS. We show many are located at the AIS, interact with known AIS proteins, and their
loss disrupts AIS structure and function. Our results provide conceptual insights and a
resource for AIS molecular organization, the mechanisms of AIS stability, and polarized
trafficking in neurons.
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Axon initial segments (AISs) are located at the interfacebetween somatodendritic and axonal domains of neurons.They have two main functions: to cluster and maintain ion
channels in high densities for efficient action potential initiation1,
and to control neuronal polarity by regulating the differential dis-
tribution and trafficking of proteins, vesicles, organelles, and even
lipids between axonal and somatodendritic compartments2–4. These
properties depend on the cytoskeletal and scaffolding proteins
AnkyrinG (AnkG) and β4 spectrin. For example, loss of AnkG
blocks clustering of Na+ and K+ channels5,6, and AnkG-deficient
axons acquire dendritic features, including spines and post-synaptic
densities7. Pathogenic variants of ANK3 and SPTBN4 (the genes
encoding AnkG and β4 spectrin proteins in humans, respectively)
lead to severe intellectual disability and neuropathy8,9, while injuries
and diseases may be accompanied by rapid calpain-dependent
proteolysis of AnkG and β4 spectrin10,11. Recent studies have
yielded exciting new insights into AIS physiology, the molecular
organization of the AIS, and AIS-regulated protein trafficking12,13.
Since AIS Na+ and K+ channel clustering depends on their AnkG-
binding motifs14,15, it is easy to understand how loss of AnkG
disrupts channel clustering. In contrast, the differential trafficking of
somatodendritic and axonal proteins is controlled through micro-
tubule- and actin-dependent mechanisms, but the details remain
obscure16–18.
The gaps in our knowledge of AIS structure and function reflect
the paucity of known AIS proteins. Major conceptual advances in
AIS structure and function usually follow the identification of new
AIS proteins. For example, the recent identification of Trim46 as an
AIS-associated microtubule cross-linking factor19, and Ndel1 as a
regulator of vesicular trafficking at the AIS20, yielded key conceptual
insights into AIS structure and function. Although ion channels,
cytoskeletal scaffolds, and cell adhesion molecules have been
reported at the AIS, these likely represent only a fraction of the
proteins required for AIS function and structure. Most studies of
AIS proteins have focused on those that are enriched at the AIS.
However, many proteins may function at the AIS, but unlike AnkG
or β4 spectrin, are not restricted to the AIS. For example, although
α2 spectrin is in both axons and dendrites, a subset of α2 spectrin
forms a detergent-resistant periodic cytoskeleton at the AIS together
with AnkG and β4 spectrin21. Thus, a major challenge is to identify
proteins that participate in AIS function, but that are not exclusively
located or enriched at the AIS. In addition, a major experimental
limitation of working with AIS proteins is their detergent insolu-
bility due to their association with the AnkG-dependent AIS
cytoskeleton; this renders them refractory to purification by con-
ventional immunoaffinity approaches.
We report here the use of proximity biotinylation to overcome the
unique experimental challenges of the AIS. We describe a multi-
plexed strategy that revealed AIS proteins. For some, we describe
previously unreported functions. We propose this spatially segregated
AIS proteome will be a valuable resource for further study of AIS
components, and that this proteome will help overcome the current
bottleneck to understanding AIS structure and function.
Results
Targeting BirA* to the AIS. To identify the AIS proteome we used
BirA*-dependent proximity biotinylation22. We directed the pro-
miscuous biotin-ligase BirA* to the AIS by fusing it to hemagglutinin
(HA)-tagged neurofascin-186 (NF186; Fig. 1a); NF186 is a trans-
membrane cell adhesion molecule highly enriched at the AIS. BirA*
catalyzes the addition of biotin to lysine residues with an effective
range of ~10 nm23. Thus, proteins within 10 nm of NF186-BirA* will
be biotinylated. The high affinity between biotin and streptavidin
permits stringent solubilization conditions to purify proteins that are
strongly associated with the cytoskeleton; biotinylated proteins can be
purified using streptavidin affinity capture, and then identified using
mass spectrometry (Fig. 1a). NF186 is targeted to the AIS by its
interaction with AnkG. The presence of endogenously biotinylated
proteins24 and the promiscuity of the BirA* ligase means that
appropriate controls are essential. Therefore, we constructed a
mutant NF186-BirA* chimera by deleting the cytoplasmic five amino
acid sequence (FIGQY) that mediates its interaction with AnkG
(Fig. 1a)25. Since NF186ΔFIGQY-BirA* does not localize to the AIS,
biotinylated proteins can be compared to those identified using
NF186-BirA*; proteins that are more abundant in the NF186-BirA*
purification are candidate AIS proteins (Fig. 1a).
We packaged the large NF186-BirA* and NF186ΔFIGQY-BirA*
constructs in adenovirus for transduction of hippocampal neurons
in vitro. Importantly, the expression of these chimeras was driven
by the human neuron-specific enolase (NSE) promoter, since
stronger expression using CAG, CMV, EF1α, or hSyn promoters
overwhelmed the targeting and clustering machinery resulting in
mislocalized proteins. We infected hippocampal neurons at DIV11,
and found that by DIV14, NF186-BirA* was enriched at the AIS
where it colocalized with β4 spectrin (Fig. 1b). In contrast,
NF186ΔFIGQY-BirA* was not restricted to the AIS and instead
distributed throughout the cell (Fig. 1b). At DIV13, we added
50 μM biotin to the neuron culture medium. One day later
(DIV14), the AIS of NF186-BirA*-expressing neurons were strongly
labeled by streptavidin, but NF186ΔFIGQY-BirA*-expressing
neurons had diffuse streptavidin labeling (Fig. 1b). Biotinylated
proteins were detected in the soma cytoplasm, but did not strongly
colocalize with HA immunostaining, suggesting that this represents
endogenously biotinylated proteins. Thus, AIS-localized NF186-
BirA* chimeras efficiently biotinylate AIS proteins.
Mining the NF186 proximity proteome. To identify biotinylated
AIS proteins, we solubilized DIV14 transduced and biotin-treated
neurons, captured biotinylated proteins using streptavidin coated
beads, then identified captured proteins using mass spectrometry.
For each protein, we plotted the number of peptide spectral
matches (PSMs) as a measure of its enrichment and proximity to
NF186-BirA* (Fig. 1c, d). For simplicity, each protein is indicated
by its gene name; thus, AnkG is Ank3 and β4 spectrin is
Sptbn4. Proteins found at the AIS should have more PSMs present
in the NF186-BirA* samples compared to proteins purified from
NF186ΔFIGQY-BirA* expressing neurons (Fig. 1c, d). Proteins
that are non-specifically or intrinsically biotinylated (e.g., car-
boxylases Mccc1 and Pcca24), should have approximately equal
numbers of PSMs in both NF186-BirA* and NF186ΔFIGQY-
BirA* samples. These proteins reside along the diagonal least-
squares fit of all purified proteins (Fig. 1c, d, solid diagonal lines).
To reduce false positives, we used a stringent cutoff and only
investigated proteins biotinylated by NF186-BirA* with at least ten
PSMs, and that were above a line parallel to the least-squares fit
(Fig. 1c, d, dashed line); this does not mean that proteins below a
cutoff of 10 are not AIS proteins, and a less stringent cutoff may
yield more candidates. Thus, proteins found above the dashed line
in Fig. 1c, d are candidate AIS proteins (Fig. 1d is a magnified view
of Fig. 1c). We found the previously described AIS proteins AnkG
(Ank3), α2 spectrin (Sptan1), NF186 (Nfasc), β4 spectrin (Sptbn4),
and Nav1.2 (Scn2a; Fig. 1c, d, red) were enriched in the NF186-
BirA* expressing neurons compared to NF186ΔFIGQY-BirA*
expressing neurons. We also found AnkB (Ank2) and β2 spectrin
(Sptbn1) were enriched in the NF186-BirA* samples (Fig. 1c, red),
since NF186 is found at low densities in distal axons where it
interacts with a cytoskeletal complex consisting of AnkB and
β2 spectrin26,27, and β2 spectrin was reported at the AIS28.
We also ranked the biotinylated proteins with PSM counts in the
NF186-BirA*-expressing neurons at least twofold above that of
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NF186ΔFIGQY-BirA* expressing neurons (Fig. 1e). The greatest
enrichment for proteins in proximity to NF186 are AnkG (Ank3)
and AnkB (Ank2); this is consistent with our strategy to use the
non-ankyrin binding NF186ΔFIGQY-BirA* chimera as a control.
Altogether, these observations demonstrate the robustness of our
approach using proximity biotinylation to capture AIS proteins.
Using the proteins enriched in the NF186-BirA* sample (Fig. 1e),
we generated a protein interaction network using Cytoscape and the
STRING database of protein–protein association networks29,30.
This network revealed a module with previously known AIS
functions (Ankyrins and Spectrins, yellow), a module not previously
described (Septins, red), and many proteins with no previously
reported connection to NF186 or AIS (Fig. 1f, white).
To confirm potential AIS proteins, we combined results
from four independent experiments (Supplementary Data 1).
We identified all PSM count ratios > 2 between NF186-BirA*
expressing neurons and NF186ΔFIGQY-BirA* expressing neu-
rons (Fig. 2a). A search of the literature revealed that among the
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73 proteins preferentially biotinylated in NF186-BirA* expressing
neurons, 33% are scaffolding/cytoskeletal proteins and 14%
participate in vesicle trafficking.
Since we identified so many candidate AIS proteins, we focused
on those that were most enriched (Figs. 1e and 2a), comprises a
module (Septins), and had available antibodies. To confirm AIS
proteins, we used three criteria: (1) the protein is located at the AIS,
(2) the candidate interacts with known AIS proteins, and (3) loss of
the candidate perturbs AIS structure or function. We do not suggest
that AIS proteins must have any or all of these characteristics, but to
find AIS proteins and demonstrate the utility of our approach, these
criteria are robust and stringent. Below, we describe examples of
proteins that satisfy these criteria and that provide conceptual
insights into AIS structure and function.
To determine if a candidate is associated with the AIS, we
immunostained DIV12-14 hippocampal neurons. In parallel, we
immunolabeled neurons extracted with TX-100 prior to fixation to
remove soluble proteins. For example, α2 spectrin (Sptan1; Figs. 1c
and 2a), is the only neuronal α spectrin and is required for the
function of all β-spectrins in somatic, dendritic, and axonal
Fig. 1 Proximity biotinylation using NF186-BirA* reveals AIS-associated proteins. a The experimental strategy using BirA*-dependent proximity
biotinylation to identify AIS proteins. b Immunolabeling of DIV14 hippocampal neurons transduced at DIV11 using adenovirus to express HA-tagged NF186-
BirA* and NF186ΔFIGQY-BirA*. From DIV13, neuronal culture media included 50 μM biotin. AIS (arrowheads) are labeled using antibodies against
β4 spectrin (blue). The NF186-BirA* and NF186ΔFIGQY-BirA* chimeras are labeled using anti-HA antibodies (red). Biotinylated proteins were detected
using Alexa488-conjugated Streptavidin. Scale bar= 5 μm. c, d The number of peptide spectral matches (PSMs) for each biotinylated protein identified by
mass spectrometry and shown at different scales. Known AIS and NF186-interacting proteins are indicated in red. The solid line is the least-squares fit of
the biotinylated proteins while the dotted lines parallel to the least-squares fit line represent an arbitrary minimum of ten PSMs confidence interval. PSMs
are the average PSM counts for two independent replicates for each chimera. e Rank plot showing the enrichment of NF186-BirA* PSMs over
NF186ΔFIGQY-BirA* PSMs. f Protein interaction network generated using Cytoscape and the STRING database of protein interactions. With the exception
of Nfasc, the size of each circle is proportional to the ratio of the PSMs count for each protein indicated. White circles include proteins with no previously
reported function at the AIS. Yellow circles correspond to the ankyrin/spectrin network, and red circles correspond to the septin network.
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Fig. 2 Candidate AIS proteins and their sensitivity to detergent extraction. a The ratio (Log2) of PSMs in NF186-BirA*-expressing neurons to PSMs in
NF186ΔFIGQY-BirA*-expressing neurons. Known AIS proteins are shown in red. An endogenously biotinylated carboxylase (Acaca), that is equally biotinylated
in both NF186-BirA* expressing neurons and NF186ΔFIGQY-BirA* expressing neurons, is shown for reference. Dashed lines at 1 indicate twofold enrichment, or
equal levels of biotinylation at 0. n= 4 independent experiments. Error bars, ±SEM. b Immunostaining of DIV14 hippocampal neurons using antibodies against
AnkG (red), α2 spectrin (green), and Map2 (blue). The lower panels show the Triton X-100 detergent-resistant pool of α2 spectrin at the AIS. AIS are indicated
by arrowheads. Scale bar= 5 μm. c Immunostaining of DIV14 hippocampal neurons using antibodies against AnkG (red), Arhgap21 (green) and Map2 (blue).
The lower panels show Arhgap21 is solubilized by Triton X-100. AIS are indicated by arrowheads. Scale bar= 10 μm.
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compartments21. Thus, α2 spectrin immunoreactivity is found
throughout neurons. However, detergent extraction prior to fixation
and immunolabeling revealed a pool of insoluble α2 spectrin at the
AIS (Fig. 2b, arrowhead) that forms a periodic cytoskeleton with
β4 spectrin (Sptbn421). In contrast, immunolabeling of Arhgap21
(Arhgap21; Figs. 1e and 2a) showed widespread immunoreactivity
throughout the neuron, but was soluble in detergent (Fig. 2c).
Mical3 is a spectrin-interacting AIS protein. The first protein
we identified at the AIS was Mical3 (Mical3; Figs. 1e and 2a).
Mical proteins are oxidoreductases that function to depolymerize
F-actin31. However, Micals are catalytically inactive since they
reside in an auto-inhibited conformation in the absence of sti-
muli32. Immunostaining for Mical3 showed 98% of hippocampal
neurons had a detergent-resistant pool at the AIS that colocalized
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with AnkG (Fig. 3a, arrowhead). We defined the precise dis-
tribution of Mical3 in the AIS using super-resolution Single-
Molecule Localization Microscopy (SMLM)33. To simultaneously
visualize the AIS cytoskeleton and Mical3, we used DNA-PAINT
imaging, which allows multicolor SMLM34. Consistent with
previous reports21, we found two peaks of α2 spectrin immu-
noreactivity centered on a periodicity of ~190 nm (Fig. 3b, c).
SMLM of AIS Mical3 did not show clear periodicity, but instead
showed punctate immunoreactivity that did not overlap with
α2 spectrin (Fig. 3b, c). Line scans show that detergent-resistant
clusters of Mical3 are usually nested between α2 spectrin.
Does Mical3 interact with AIS proteins? We performed in vitro
co-immunoprecipitation experiments between Mical3 and known
AIS proteins. Although we did not detect interactions between
Mical3 and NF186 or AnkG, we found interactions between
Mical3 and AIS α2 spectrin (Fig. 3d). Immunoprecipitation of
Mical3 from brain homogenate also co-immunoprecipitated
α2 spectrin (Fig. 3e). One recent mass spectrometry-based screen
for Mical3-binding partners also reported Mical3’s top interactors
in HEK293T cells were α2 spectrin (Sptan1) and β2 spectrin
(Sptbn1)35. To define where Mical3 interacts with α2 spectrin, we
performed pull-down experiments using GST fusion protein
fragments of α2 spectrin. These experiments revealed that Mical3
binds α2 spectrin at or near its SH3 domain (AA 572-1338;
Fig. 3f). Remarkably, Mical proteins received their name and were
originally identified based on their interaction with the SH3
domain of CasL (Molecule Interacting with CasL)36.
What does Mical3 do at the AIS? We generated shRNAs to
silence Mical3’s expression. To determine if Mical3 is important
for AIS assembly, we transfected plasmids at DIV2, and examined
AIS at DIV6. Whereas control short-hairpin RNA (shRNA) had
no effect on AIS assembly (Fig. 4a, arrowhead), Mical3 shRNA
frequently disrupted or blocked AnkG clustering and AIS
assembly (Fig. 4a, b). In contrast, transfection of more mature
neurons at DIV9 did not disrupt AIS maintenance at DIV13
(Fig. 4b, c). However, silencing expression of Mical3 dramatically
altered cell morphology and increased AIS actin (Fig. 4c, box and
right, d). Similarly, transfection of the methionine sulfoxide
reductase B1 (MsrB1), a Mical3 antagonist37, did not disrupt the
AIS but instead promoted the accumulation of actin at the AIS
(Fig. 4e, f). Thus, reduced Mical3 activity in mature neurons
promotes actin accumulation at the AIS.
Although normally auto-inhibited, the enzymatic activity of
Mical proteins can be activated by Rab GTPases, and different Rabs
can interact with Micals to locally control activity38,39. For example,
the interaction between Mical3 and Rab8a regulates vesicle
exocytosis40. We confirmed Mical3 interacts with some Rab
GTPases, but not others (Fig. 4g). Dynamic actin patches at the
AIS may function as sorting stations to exclude vesicles carrying
dendritic cargoes from the axon17. To increase Mical3 activity and
to determine if Mical3 can regulate AIS actin patches, we counted
the number of AIS actin patches in neurons transfected at DIV12
with Mical3-interacting Rab GTPases used to activate Mical3’s
oxidoreductase activity. At DIV14, we found AIS actin patches in
untransfected neurons (Fig. 4h, arrowhead), but transfection of
Mical3-binding Rab8a and Rab8b significantly reduced the number
of AIS actin patches (Fig. 4i, j). However, expression of utrophin
(actin-binding), Rab35 (Mical3-non-binding), and Rab36 (Mical3-
binding) did not affect the number of AIS actin patches. These
results suggest AIS Mical3 may be bound to the AIS spectrin
cytsokeleton and activated by specific Rab GTPases found on
vesicles with axonal cargoes; we speculate activation of Mical3
disassembles AIS actin patches, permitting vesicles containing
axonal cargoes to pass through the AIS and enter the axon (Fig. 4k).
Those without the appropriate Rab GTPase reverse direction at the
actin patch17 and are excluded from the axon.
Septins stabilize and maintain AIS AnkG. The NF186-BirA*
protein interaction network included a prominent module with 5
different Septins (Sept3, Sept5, Sept6, Sept7, and Sept11; Figs. 1f
and 2a). This attracted our attention since Septins modulate the
functions of actin and microtubules, create membrane bound-
aries, and function as scaffolds—all important properties for the
AIS41. To determine if Septins are located at the AIS, we
immunostained DIV14 hippocampal neurons using antibodies
against Septins 3, 5, 6, 7, and 11. All were widely distributed
throughout neurons in both axonal and somatodendritic domains
(Fig. 5a, b and Supplementary Fig. 1). Detergent extraction prior
to fixation revealed a detergent-resistant pool of Septins 5, 6, 7,
and 11 that colocalized with AnkG (Fig. 5a, b and Supplementary
Fig. 1b, c, arrowheads). Among these Septins, Sept5 and Sept6 can
co-immunoprecipitate AnkG (Fig. 5c). Further analysis of Sept5
and 6 showed that 55 and 73% of AIS, respectively, had a
detergent-resistant pool of these proteins. Neuronal expression of
Sept5 and Sept6 deletion mutants lacking either their N- or C-
termini showed that Sept5ΔN had no effect on AIS AnkG, but
expression of Sept5ΔC blocked AIS assembly and mislocalized
AnkG to somatodendritic regions (Supplementary Fig. 2a). These
results suggest AnkG interacts with an N-terminal domain of
Sept5. In contrast, neither expression of Sept6ΔN nor Sept6ΔC
affected the AIS localization of AnkG (Supplementary Fig. 2b).
Nevertheless, expression of Sept6ΔC dramatically altered the
membrane organization of the cell by inducing the formation of
large membrane sheets in both axonal and somatodendritic
domains (Supplementary Fig. 2b).
To determine the function of AIS Septins, we silenced their
expression during early development (from DIV2 to DIV6) and
examined AIS AnkG. We found that loss of any AIS Septin
blocked AnkG clustering (Fig. 6a, b). Since Septins can regulate
microtubules, we examined how loss of Sept5 and Sept6 affects
the assembly of bundled AIS microtubules as indicated by AIS
Trim4619. Whereas silencing of AnkG reduced by ~60% the
number of neurons with AIS Trim46, silencing Sept5 and Sept6
caused even more dramatic loss of AIS Trim46 (Fig. 6c, d). Thus,
Septins are required for AIS assembly.
AIS AnkG is essential to maintain neuronal polarity7. To
determine if Septins also contribute to AIS maintenance, we
silenced expression of Sept5 and Sept6 in mature neurons since
they bind AnkG (Fig. 5c). Silencing AnkG expression from DIV9-
13 (Fig. 6e) and DIV9-17 (Fig. 6f) resulted in 22 and 37%
reduction in the number of neurons with AIS AnkG, respectively
Fig. 3 A detergent insoluble pool of spectrin-interacting Mical3 is located at the AIS. a Immunostaining of DIV14 hippocampal neurons using antibodies
against AnkG (red), Mical3 (green) and Map2 (blue). The lower panels show the Triton X-100 detergent-resistant pool of Mical3 at the AIS. AIS are
indicated by arrowheads. Scale bar= 5 μm. b DNA-PAINT super-resolution imaging of Mical3 (magenta) and α2 spectrin (green). The boxed regions in the
left panels are shown magnified in the right panels. Scale bar= 2 μm. c Line scans (gray bars) in the magnified panels in b show the normalized
fluorescence intensity. Line scans are specific to these images and are not averages across many cells. d In vitro co-immunoprecipitation shows Mical3 co-
immunoprecipitates with α2 spectrin. DS depleted supernatant, IP immunoprecipitation. e α2 spectrin co-immunoprecipitates with Mical3 from mouse
brain homogenate. f GST-pull-down experiment between Mical3-myc and GST fusion proteins including the amino acids of α2 spectrin indicated. All
molecular weight markers are in kilodaltons. Source data are provided as a Source Data file.
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(Fig. 6i); this modest reduction is consistent with AnkG’s
very long half-life7. In contrast, silencing Sept5 and Sept6
expression resulted in rapid and nearly complete loss of AIS
AnkG in both DIV9-13 (Fig. 6e, i) and DIV9-17 neurons (Fig. 6f,
i). When we examined AIS Trim46 in neurons transfected with
AnkG shRNA, we found AIS Trim46 was largely preserved
in both DIV9-13 (Fig. 6g, j) and DIV9-17 neurons lacking
AnkG (Fig. 6h, j). Remarkably, in contrast to loss of AIS AnkG,
silencing Sept5 and Sept6 did not affect AIS Trim46 in DIV9-13
neurons (Fig. 6g, j); the effect of Septin loss on Trim46 takes
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longer than the effect on AnkG, and Trim46 is lost from the
AIS only in DIV9-17 neurons (Fig. 6h, j). The concurrent
retention of AIS Trim46 and loss of AnkG after Septin
knockdown, with loss of Trim46 much later than AnkG, reveals
that AIS Septins function to directly stabilize and maintain AIS
AnkG in neurons. Thus, proximity biotinylation using NF186-
BirA* reveals AIS proteins, leading to conceptual insights for AIS
structure and function.
Ndel1 proximity proteome maps the shallow AIS cytoplasm.
Three-dimensional (3D) STORM imaging previously showed that
NF186 and Nav channel interactions with AnkG occur about 8 nm
above β4 spectrin (Fig. 7a)42. Therefore, AIS proteins found deeper
in the AIS cytoplasmmight be missed using a membrane-associated
BirA* chimera since its range is only ~10 nm. Therefore, we used
the AIS cytoplasmic protein Ndel120 to map the deeper molecular
structure of the AIS (Fig. 7a). The C-terminal half of Ndel1
(Ndel1C; amino acids 166 to 345) binds to the C-terminus of AnkG
(~32 nm below the AIS membrane)42 and mediates its localization
to the AIS20. Unfortunately, the precise amino acids responsible for
Ndel1’s AIS targeting are unknown; thus, we could not use a control
chimera like the non-localizing NF186ΔFIGQY-BirA*. In a pilot
experiment we compared proteins biotinylated by BirA* alone to
the pool of endogenously biotinylated proteins. BirA* alone has
been used as a control for biotinylation in vivo43. We found that
after adenovirus-mediated delivery of BirA*, the biotin-ligase alone
is found throughout the neuron and biotinylates tubulins (Sup-
plementary Fig. 3). Nevertheless, we were concerned that BirA*
alone might be a poor control for chimeras specifically targeted to
distinct domains or compartments (AIS, membrane, etc.). As an
alternative strategy to reveal proteins in the vicinity of AIS Ndel1,
we constructed two chimeras consisting of the HA-tagged Ndel1C
AnkG-binding domain and BirA* linked to the N- (BirA*-Ndel1C)
or C-terminus (Ndel1C-BirA*). Since the N- and C-terminal BirA*
are separated by a largely unstructured 179 amino acids44, the
contour length of Ndel1C (3.4–4.0 Å/residue)45 suggests the two
chimeras may map regions as much as ~60–70 nm apart. Thus, by
comparing these chimeras we can spatially map the AIS cytoplasm.
We packaged these in adenoviruses, transduced DIV11 neurons,
and found that by DIV14 the chimeras were enriched at the AIS
and colocalized with NF186 (Nfasc). Addition of biotin at DIV13
resulted in biotinylation of AIS proteins by DIV14 (Fig. 7b); we
purified the biotinylated proteins and performed mass spectro-
metry. We then compared proteins biotinylated by the Ndel1C-
BirA* chimera, to proteins biotinlyated by the BirA*-Ndel1C
chimera (Fig. 7c–e). We found that Ndel1C-BirA* biotinylated its
binding partner Lis1 (Pafah1b1; also located at the AIS20) and
AnkG (Ank3) more efficiently than the Ndel1C-BirA* chimera
(Fig. 7d, e), suggesting that it is oriented with the BirA* towards the
membrane and AnkG (Fig. 7a).
To further confirm AIS proteins, we combined results from two
independent experiments (Supplemenary Data 1). We identified all
PSM count ratios >2 between Ndel1C-BirA* and BirA*-Ndel1C
chimeras (Fig. 7f). We found that 20/55 proteins preferentially
biotinylated by the Ndel1C-BirA* chimera were common to those
biotinylated by NF186-BirA* (Fig. 7f, blue). For example, Map6 and
Klc1 were identified and enriched in the Ndel1C-BirA* biotinylated
proteins >2-fold over BirA*-Ndel1C biotinylated proteins (Fig. 7f).
Map6 was previously reported in axons and shown to stabilize
microtubules46, while Klc1 participates with kinesin heavy chains to
transport cargoes along microtubules. Importantly, antibodies
against Map6 and Klc1 label detergent insoluble AIS pools (98%
and 88% of AIS, respectively; Supplementary Fig. 4a, e). Both
interact with AnkG (Supplementary Fig. 4b, f), and silencing of each
using shRNA disrupted or blocked AIS assembly to varying degrees
(Supplementary Fig. 4c, d, g, and h). Thus, two independent
proximity biotinylation experiments using unique AIS-targeted
chimeras converge on many of the same proteins, strongly
suggesting they are AIS proteins. The range of the BirA* also
implies that proteins biotinylated by Ndel1C-BirA* and NF186-
BirA* are located in a shallow region of the AIS cytoplasm that is
spanned by AnkG (Fig. 7a).
In addition to proteins preferentially biotinylated by both
Ndel1C-BirA* and NF186-BirA* (Fig. 7c–f, blue), we also found
proteins that were preferentially biotinylated by Ndel1C-BirA* but
not NF186-BirA*, suggesting that they reside deeper in the AIS
cytoplasm. For example, immunolabeling of Ranbp2 (Ranbp2)
showed it is enriched at the AIS of cultured neurons prior to
detergent extraction (Fig. 7g). Ranbp2, although traditionally
thought to be part of the nuclear pore complex47, may participate
in a trafficking complex, including Klc1 (Fig. S4e–h) and the
kinesins Kif5b and Kif5c48. Similarly, Macf1 (Macf1; microtubule
actin cross-linking factor 1) was preferentially biotinylated by
Ndel1C-BirA*, but not NF186-BirA*. We determined Macf1’s
location since it coordinates interactions between microtubules
and F-actin, and regulates polarization of cells49. Immunolabeling
of Macf1 revealed a detergent-resistant pool at the AIS in 92% of
neurons examined (Fig. 7h). These results show that proximity
biotinylation using AIS-targeted Ndel1C can reveal AIS proteins
and map their relative locations in the AIS.
An important consideration with this experimental design,
compared to that using NF186-BirA* and NF186ΔFIGQY-BirA*
chimeras, is that both Ndel1C chimeras localize to the AIS. Thus,
proteins that are in equal proximity to the BirA* on Ndel1C
N- and C-termini, i.e., close to the middle of Ndel1C, will not be
preferentially biotinylated by one specific chimera and instead will
lie along the least-squares fit line and within our 10 PSM cutoff
Fig. 4 Mical3 regulates AIS assembly and actin patches. a Immunostaining of DIV6 hippocampal neurons transfected at DIV2 with pSuper or
Mical3 shRNA. Scale bar= 20 µm. b Quantification of neurons with intact or no/disrupted AIS after transfection with pSuper control shRNA, or two
different Mical3 shRNAs at DIV2-6 or DIV9-13. n= 3 independent experiments and total number of neurons counted is shown. Error bars, ±SEM. c
Immunostaining of DIV13 hippocampal neurons transfected at DIV9 with pSuper or Mical3 shRNA. Scale bar= 10 µm. d Quantification of the percentage of
neurons transfected with the indicated shRNA that show AIS enriched with actin. n= 3 independent experiments/condition with 15 neurons/condition.
Error bars, ±SEM. e Immunostaining and labeling of hippocampal neurons transfected with MsrB1 cDNA. Phalloidin (red), MsRB1 (green), and Nfasc (blue).
Arrowheads indicate the AIS. Scale bar= 10 µm. f Quantification of the percent of AIS enriched with actin as indicated by phalloidin labeling in the presence
or absence of MsrB1. n= 3 independent experiments/condition with 10 neurons/condition. Error bars, ±SEM. g In vitro immunoprecipitation of Mical3-myc
using myc antibodies co-immunoprecipitates some tRFP tagged RabGTPases. IP immunoprecipitation, IB immunoblotting. Molecular weight markers are in
kilodaltons. h, i Labeling of AIS actin patches (arrowhead) using phalloidin (green) in untransfected DIV 14 neurons (h), or Rab8a-tRFP-transfected DIV 14
hippocampal neurons using phalloidin (green) and antibodies against Nfasc (blue) and tRFP (red) (i). Actin patches are indicated by the arrowhead. Scale
bar= 10 µm. j The number of actin patches/AIS in neurons transfected with the indicated plasmid. n= 3 independent experiments with 10 neurons/
experiment. (F= 52.63, df total= 20) ***p= 8.29 × 10−9; one-way ANOVA. Error bars, ±SEM. k Model for Mical3 function at the AIS. The cartoon
illustrates that Rab GTPases on vesicles carrying axonal cargoes activate Mical3, resulting in depolymerization of actin patches. Vesicles carrying
somatodendritic cargoes reverse direction at actin patches and do not enter the axon. Source data are provided as a Source Data file.
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range (Supplementary Fig. 5a, b). Many of these common proteins
with the highest number of peptides were tubulins (Fig. 7c).
Trim46 proximity proteome maps AIS microtubules. One
unique structural feature of the AIS is the presence of fasciculated
microtubules50; these microtubules are distributed through the
AIS (average depth of ~85 nm42). Trim46 is enriched at the AIS,
regulates neuronal polarity, and bundles microtubules (Fig. 7a); a
truncated Trim46 lacking its C-terminus (Trim46ΔC) is sufficient
to localize at the AIS19. However, the amino acids mediating
Trim46’s AIS localization are unknown. Therefore, to identify
proteins that participate in AIS microtubule functions, AIS
microtubule composition, and to probe the molecular organiza-
tion of the fasciculated microtubule domain, we used the same
strategy as we did for Ndel1: we constructed myc-tagged
Trim46ΔC-BirA* and BirA*-Trim46ΔC chimeras. We packaged
these in adenovirus, and transduced DIV11 neurons. By DIV14,
we found Trim46ΔC-BirA* and BirA*-Trim46ΔC were enriched
at the AIS, but did not precisely colocalize with NF186 since
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NF186 is a transmembrane protein while Trim46ΔC chimeras
decorate the AIS microtubule cytoskeleton (Fig. 8a, BirA*-
Trim46ΔC is not shown). Addition of biotin at DIV13 caused
biotinylation of the AIS microtubule compartment by DIV14
(Fig. 8a). We transduced neurons using the Trim46ΔC-BirA* or
BirA*-Trim46ΔC chimeras, and then performed mass spectro-
metry on biotinylated proteins. After removing the endogenously
biotinylated carboxylases, we found that biotinylated proteins,
most prominently tubulins, were found near the least-squares
fit line (Supplementary Fig. 6a). Interestingly, when we identi-
fied proteins that were preferentially biotinylated by Trim46ΔC-
BirA* (twofold over BirA*-Trim46ΔC; Supplementary Fig. 6b),
we found that 2/77 are known AIS proteins (Fig. 8d and Sup-
plementary 6b, red), 9/77 are also preferentially biotinylated
by both NF186-BirA* and Ndel1C-BirA* (Fig. 8d and Supple-
mentary Fig. 6b, blue), and 9/77 are also preferentially biotiny-
lated by Ndel1C-BirA* (Fig. 8d and Supplementary Fig. 6b,
green). Thus, proximity biotinylation using Trim46ΔC-BirA*
and BirA*-Trim46ΔC further defines the molecular organization
of the AIS.
To gain additional insight into the microtubule compartment
of the AIS, we performed a separate experiment where we pooled
proteins biotinylated by Trim46ΔC-BirA* and BirA*- Trim46ΔC
(collectively referred to as Trim46-BirA*). We compared these
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biotinylated proteins to proteins biotinylated in sister cultures
expressing BirA*-Ndel1C or Ndel1C-BirA* chimeras, since our
results suggest the Ndel1C-BirA* is oriented toward AnkG,
while BirA*-Ndel1C is oriented away from AnkG. Comparison of
Ndel1C-BirA* with Trim46-BirA* showed Ndel1C-BirA* prefer-
entially biotinylated known AIS proteins (red) and proteins we
identified as interacting with AnkG (e.g., β4 spectrin and Map6;
Fig. 8b, c).
Since Ndel1 regulates dynein activity along microtubules, and
BirA*-Ndel1C is oriented with the BirA* away from AnkG
(Fig. 7), we considered whether BirA*-Ndel1C and Trim46-BirA*
chimeras biotinylate a similar pool of proteins, resulting in most
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identified proteins near the least-squares fit line (Fig. 8e). Similar
to our results comparing Trim46ΔC-BirA* and BirA*-Trim46ΔC
(Supplementary Fig. 6a), we found many tubulin subunits were
biotinylated by both Trim46-BirA* and BirA*-Ndel1C.
Since many tubulin subunits were identified using the non-
AIS-targeting chimera NF186ΔFIGQY-BirA* (Fig. 1c) or BirA*
alone (Supplementary Fig. 3a), it is possible that tubulins are
simply non-specifically biotinylated proteins in the Trim46-BirA*
experiments. However, tubulins are part of the AIS cytoskeleton.
Therefore, to determine which tubulins are retained as part of the
AIS cytoskeleton, we immunostained cultured hippocampal
neurons with, and without prior detergent extraction, using
tubulin antibodies. We found that α tubulins (Tuba1a (Tuba1a)
and Tuba4a (Tuba4a)) and β-tubulins (Tubb3 (Tubb3) and
Tubb5 (Tubb5)) labeled both axonal and somatodendritic
compartments (Fig. 7f–i). However, 95%, 99%, 97%, and 98%
of neurons also had a detergent-resistant AIS pool of Tuba1a,
Tuba4a, Tubb3, and Tubb5, respectively (Fig. 7f–i, arrowheads).
Thus, proximity biotinylation using Ndel1C and Trim46ΔC
chimeras reveal tubulin subunits that may be part of the unique
microtubule cytoskeleton found at the AIS.
Discussion
We used molecular targeting of the biotin-ligase BirA* to map the
molecular organization of the AIS. BirA* can be used both in vitro
and in vivo to identify proteomes based on proximity. For
example, Kim et al.23 used BirA* in HEK293 cells to investigate
the nuclear pore complex, while Uezu et al.43 targeted BirA*
in vivo to excitatory and inhibitory synapses using PSD-95-BirA*
and Gephyrin-BirA* chimeras, respectively. The experiments in
neurons yielded robust proteomes for inhibitory and excitatory
synapses. Other methods for proximity biotinylation (e.g., APEX)
also provided important insights into synapse structure51. How-
ever, proximity biotinylation using BirA* or APEX is limited to a
range of ~10 nm. Thus, for structures larger than a post-synaptic
density (e.g., AIS), a multiplexed approach is necessary to improve
coverage and specificity. For example, we found significant overlap
between the proteins biotinylated by NF186-BirA* and Ndel1C-
BirA* (Fig. 8d). Discovery of the same proteins using independent
AIS-targeting strategies significantly increases our confidence that
the identified proteins are AIS proteins.
This multiplexed approach can be replicated in other subcellular
compartments and domains (e.g., organelles, growth cones, etc.), and
our experiments in neurons serve as a paradigm. Our experiments at
the AIS also emphasize the importance of appropriate controls and
experimental design. Here, we used two separate approaches: a non-
targeting chimera, and chimeras with BirA* attached to different
locations of the bait protein. We found both methods effectively
revealed AIS proteins, but also missed several known AIS membrane
and membrane-associated proteins, including Nav1.6, NrCAM,
KCNQ2/3K+ channels, Caspr2, Kv1 K+ channels, and PSD-9312,52.
The limited range of BirA* may account for the absence of some of
these AIS proteins, and reinforces the importance of using multiple
independent chimeras to improve coverage of the AIS protein
landscape. In some instances, membrane proteins were missed due to
our stringent peptide cutoff. Application of extracellular proximity
biotinylation might also yield better representation of membrane and
membrane-associated proteins, including AIS-enriched extracellular
matrix molecules53. Alternatively, we may have missed some AIS
membrane proteins since we collected biotinylated proteins at
DIV14, before most AIS are fully mature. Thus, future experiments
using NF186-BirA* and NF186ΔFIGQY-BirA* chimeras at different
developmental stages, together with AIS-specific extracellular proxi-
mity biotinylation, may uncover AIS proteins that are devel-
opmentally regulated or that play key roles in later events, including
the formation of AIS axo-axonic synapses54. The selective purifica-
tion of spatially distinct pools of proteins using proximity biotiny-
lation and mass spectrometry can also be used to examine post-
translational modifications. For example, the AIS is a hotspot for
protein phosphorylation18,55,56, and subsequent analysis of biotiny-
lated AIS proteins may define the specific phosphorylation sites,
among other modifications.
The AIS is highly enriched with cytoskeletal proteins, including
Ankyrins, Spectrins, actin, and tubulins. Since the chimeras we
used all relied on interaction with this cytoskeleton, it is not
surprising that the AIS proteins we identified are related to
cytoskeletal functions. The close association with AIS cytoskeletal
proteins renders many AIS proteins detergent insoluble, and we
used this as one characteristic of AIS proteins. An important
advantage of our AIS-restricted proximity biotinylation strategy is
that it allowed us to identify proteins that participate in AIS
structure and function, but that are not found exclusively at the
AIS. This vastly expands the repertoire of proteins that can be
investigated to determine the mechanisms regulating AIS func-
tions, including neuronal polarity and trafficking of axonal and
dendritic vesicles and organelles.
Our experiments provide an important resource for future
studies of AIS structure and function. Many of the identified
proteins suggest mechanisms regulating protein trafficking, AIS
stability, and cytoskeletal plasticity. For example, we showed that
one of the most highly biotinylated proteins using the NF186-
BirA* chimera is Mical3. Mical3 interacts with AIS spectrins, a
detergent-resistant subset of Mical3 is located at the AIS, and
knockdown of Mical3 resulted in accumulation of actin at the
AIS. Further, our experiments suggest that activation of Mical3 by
Rab proteins alters the structure of AIS actin patches. Thus, we
speculate that Mical3 may help regulate the differential trafficking
Fig. 7 The Ndel1 proximity proteome. a Cartoon of BirA*-containing chimeras used to identify AIS proteins and their locations relative to β4 spectrin (not
shown). b Immunolabeling of DIV14 hippocampal neurons transduced at DIV12 using adenovirus to express HA-tagged Ndel1C-BirA* and BirA*-Ndel1C. AIS
are labeled using antibodies against Neurofascin (Nfasc, blue). The Ndel1C-BirA* and BirA*-Ndel1C chimeras are labeled using anti-HA antibodies (green).
Biotinylated proteins were detected using Alexa594-conjugated Streptavidin. Scale bar= 5 μm. c, d The number of PSMs for each protein biotinylated by
Ndel1C-BirA* and BirA*-Ndel1C, and identified by mass spectrometry; panels c and d are shown at different scales. Known AIS proteins are indicated in red.
Proteins enriched and previously identified as candidate AIS proteins in the NF186-BirA* samples are indicated in blue. The solid line is the least-squares fit of
the biotinylated proteins while the dotted lines parallel to the least-squares fit line represent an arbitrary minimum of ten PSMs confidence interval. Peptide
counts for BirA*-Ndel1C are the average of two replicates, while results for Ndel1C-BirA* are from one experiment. e Rank plot showing the enrichment of
PSMs for a given protein in the Ndel1C-BirA* samples over the PSMs for a given protein found in the BirA*-Ndel1C samples. Known AIS proteins are
indicated in red. Proteins enriched and previously identified as candidate AIS proteins in the NF186-BirA* samples are indicated in blue. f The average ratio
(Log2) of PSMs in Ndel1C-BirA* to PSMs in BirA*-Ndel1C expressing neurons. Known AIS proteins shown in red. Proteins also identified using NF186-BirA*
chimeras shown in blue. Dashed lines indicate twofold enrichment, or equal levels of biotinylation. n= 2 independent experiments. g Immunostaining of
DIV14 cultured hippocampal neurons using antibodies against AnkG (red), Ranbp2 (green), and Map2 (blue). The lower panels show detergent-resistant
Ranbp2 at the AIS. AIS are indicated by arrowheads. Scale bar= 5 µm. h Immunostaining of DIV14 cultured hippocampal neurons using antibodies against
AnkG (red), Macf1 (green), and Map2 (blue). The lower panels show the detergent-resistant Macf1 at the AIS. Arrowheads indicate. Scale bar= 5 µm.
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of proteins and organelles in neurons17. Future studies will be
needed to verify and better define this mechanism. It is likely that
a Mical3-dependent mechanism is but one of many involved in
sorting of cargoes in the AIS. For example, the identification of
Ranbp2 and AnkG-interacting Klc1 at the AIS, both of which
have been reported to participate in a trafficking complex in other
cells48, points to yet a different mechanism that deserves addi-
tional investigation.
The discovery of AIS Septins is consistent with their recognized
roles in cytoskeletal remodeling and polarity41. Septin filaments
can form membrane boundaries that restrict the lateral diffusion
of membrane proteins and lipids57. Since we mainly identified
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Septins using the NF186-BirA* chimera, this suggests they are in
a privileged location and not accessible to biotinylation by
Ndel1C-BirA*. We previously reported that AnkG is restricted to
the AIS through the formation of an intra-axonal membrane
boundary made by AnkB and β2 spectrin. Since NF186-BirA*
biotinylated both AnkB and β2 spectrin, Septins may also func-
tion in the distal axon. One previous study of Septins in neurons
focused on Septins 3, 5, 6, 7, and 11 (the same Septins we found
in our experiments) since their expression increases during
development and they are highly expressed in axons. Consistent
with an important role in axons, reducing expression of Sept5 or
Sept7 by shRNA disrupted axon growth58. Here, we showed that
loss of Septins disrupted the AnkG-dependent AIS cytoskeleton.
However, in mature neurons the AIS microtubule compartment
defined by Trim46 was initially resistant to disruption, suggesting
that AnkG’s remarkable stability and low turnover rate59 may
reflect its interactions with Septins at the plasma membrane.
Mical3, Septins, Map6, Klc1, Ranbp2, and Macf1 are but a few
of the AIS proteins identified and verified in our experiments.
Their discovery at the AIS demonstrates that targeted and mul-
tiplexed proximity biotinylation is a powerful approach to spatially
and molecularly map subcellular proteomes. The AIS proteome
reported here also includes many other interesting proteins with
functions that may be important at the AIS, but that we have not
investigated. For example, members of the collapsin response
mediator protein (Crmp) family were preferentially biotinylated
by NF186-BirA* (Crmp2 (Dpysl2), Crmp3 (Dpysl4) and Crmp5
(Dpysl5)), Ndel1C-BirA* (Crmp3 (Dpysl4) and Crmp5 (Dpysl5)),
and Trim46ΔC-BirA* (Crmp2(Dpysl2) and Crmp4 (Dpysl3)).
Crmp2 is a key regulator of neuronal polarity60, and a recent
report showed that loss of AnkG promotes microtubule instability
through phosphorylation of CRMP261. Crmp2 also binds directly
to Klc162. Thus, members of the Crmp family may play many, as
yet undiscovered, roles at the AIS.
The NF186, Ndel1, and Trim46 proximity proteomes led to
conceptual insights for mechanisms regulating AIS structure and
function. We suggest our results should be used as a path forward
by neurobiologists interested in the molecular mechanisms
whereby AIS regulate protein trafficking, neuronal polarity, and
axon function.
Methods
Animals. Timed pregnant Sprague-Dawley rats were obtained from Harlan
Sprague-Dawley. Rats were killed for embryo collection at E18. All experiments
were performed in compliance with the National Institutes of Health Guide for the
Care and Use of Laboratory Animals and were approved by the Baylor College of
Medicine Institutional Animal Care and Use Committee.
Adenovirus production. ViraPower Adenoviral Promoterless Gateway Expression
Kit (Invitrogen) was used to construct adenovirus. The pENTR11 shuttle vector
was modified by adding the human neuron-specific enolase promoter (hENO2)
from Addgene (Plasmid #11606). The hENO2 promoter was amplified by PCR and
inserted into pENTR11 and named pENTR11-hENO2-MCS. BirA* was amplified
by PCR from pcDNA3.1 Myc-BirA(R118G)-MCS (Addgene, Plasmid #35700) to
generate a shuttle template named pENTR11-hENO2-MCS-BirA*-MCS. To gen-
erate pENTR11-hENO2-HA-NF186-Myc-BirA* and pENTR11-hENO2-HA-
NF186ΔFIGQY-Myc-BirA*, complementary DNA (cDNA) encoding HA-NF186
and NF186ΔFIGQY were amplified by PCR from Rat NF186 tagged with an N-
terminal HA epitope tag53. pENTR11-hENO2-Ndel1C-Myc-BirA* and pENTR11-
hENO2-Myc-BirA*-Ndel1C were generated by amplifying Ndel1C (Origene) and
inserting it into shuttle template pENTR11-hENO2-MCS-BirA*-MCS. pENTR11-
hENO2-Trim46ΔC -Myc-BirA* and pENTR11-hENO2-Myc-BirA*- Trim46ΔC
were generated by amplifying Trim46 (Origene) and inserting it into shuttle
template pENTR11-hENO2-MCS-BirA*-MCS. All shuttle vectors were cloned into
pAd/PL-DEST (Gateway destination vector) by LR recombination reaction
between each entry clone (pENTR11-hEno2-HA-NF186-Myc-BirA*, pENTR11-
hENO2-HA-NF186ΔFIGQY-Myc-BirA*, pENTR11-hENO2-Ndel1C-Myc-BirA*,
pENTR11-hENO2-Myc-BirA*-Ndel1C, pENTR11-hENO2-Trim46ΔC-Myc-BirA*,
and pENTR11-hENO2-Myc-BirA*-Trim46ΔC) and a pAd/PL-DEST according to
the manufacturer’s instruction (Life Technologies) to generate pAd/PL-DEST-
hEno2-HA-NF186-Myc-BirA*, pAd/PL-DEST-hEno2-HA-NF186ΔFIGQY -Myc-
BirA*, pAd/PL-DEST-hENO2-Ndel1C-Myc-BirA*, pAd/PL-DEST-hENO2-Myc-
BirA*-Ndel1C, pAd/PL-DEST-hENO2-Trim46ΔC-Myc-BirA*, and pAd/PL-
DEST-hENO2-Myc-BirA*-Trim46ΔC, respectively. The expression clones were
digested with Pac I to expose the viral inverted terminal repeats (ITRs). First
generation adenoviruses were produced as described in ref. 63. Briefly, adenoviral
vectors were rescued by digesting the adenoviral plasmids with PacI followed by
transfection into 293 cells64 by calcium phosphate co-precipitation. Individual, well
isolated plaques were picked and expanded by infecting 293 cells. 293N3S cells65
were used for large scale adenoviral vector production in spinner cultures.
Plasmids. Plasmids for mouse Sept3, Sept5, Sept6, Sept7, Sept11, KLC1, and
MsrB1 were purchased from Origene. GFP-UtrCH plasmid was from Addgene. α2-
spectrin-GFP was gift from Dr. Michael Stankewich (Yale University). Mouse
Mical3-6xMyc, was a gift from Dr. Alex Kolodkin (Johns Hopkins University).
Macf1-GFP was a gift from Dr. Elaine Fuchs (Rockefeller University). The full-
length β4 Σ1-spectrin with N-terminal myc tag was subcloned and inserted into
pCS3+MT expression vector. Rab8a, Rab8b, Rab13, Rab35, Rab36 cDNAs were
amplified by PCR using a mouse brain cDNA library and inserted into pTagRFPC1
vector (Evrogen).
shRNA plasmid construction. The 19 or 21-nucleotide shRNA oligos were syn-
thesized by Millipore Sigma and annealed. The shRNAs were inserted into the BglII
and HindIII sites of GFP-expressing pSuper vector. The specific target sequence of
shRNA for P. pyralis luciferase was: 5ʹ-CGCTGAGTACTTCGAAATGTC-3ʹ;
Septin3 was targeted with Sept3-shRNA#1 (5ʹ-GACAGTGGAGATCAAAGCGA
T-3ʹ); Septin5 was targeted with Sept5-shRNA#1 (5ʹ-GCGGTGAACAACTCTGAA
TGT-3ʹ); Septin6 was targeted with Sept6-shRNA#1 (5ʹ-GCCCATCGTGGAATTC
ATTGA-3ʹ); Septin7 was targeted with Sept7-shRNA#1 (5ʹ-GATAACAGGG
TGCAGTGTTGT-3ʹ); Septin11 was targeted with Sept11-shRNA#1 (5ʹ-GGGA
TTTGGAGACCAGATTAA-3ʹ); Map6 was targeted with Map6-shRNA#1 (5ʹ-GG
TGCAGATCAGCGTGACA-3ʹ); Map6-shRNA#2 (5ʹ-GCTCCTACAGGAAC
GAATTCA-3ʹ); Klc1 was targeted with Klc1-shRNA (5ʹ-GGTGATGATG
GCCCTGTCTAA-3ʹ); Mical3 was targeted with Mical3-shRNA#1 (5ʹ-GCAGAAA
GGGAAAGCATTTAT-3ʹ), and Mical3-shRNA#2 (5ʹ-CCGCAGGAATAAGAAAG
AGAAGAAA-3ʹ). Plasmid DNA and shRNA constructs were verified by sequen-
cing (Genewiz or GenScript). Primers for construction of plasmids are included in
the Supplementary Methods.
Antibodies. The following antibodies were used (dilutions for each antibody are
indicated in parentheses): mouse monoclonal antibody anti-Septin 3 (1:200;
Fig. 8 The Trim46 proximity proteome reveals AIS tubulins. a Immunolabeling of DIV14 hippocampal neurons transduced at DIV11 using adenovirus to
express myc-tagged Trim46ΔC-BirA*. From DIV13, neuronal culture media included 50 µM biotin. AIS are labeled using antibodies against Neurofascin
(Nfasc, blue). The Trim46ΔC-BirA* chimera is labeled using anti-myc antibodies (red). Biotinylated proteins were detected using Alexa488-conjugated
Streptavidin. Scale bar= 5 µm. b, c Comparison of the peptide spectral matches (PSMs) for each protein biotinylated by Ndel1C-BirA* and proteins
identified using combined Trim46ΔC-BirA* and BirA*-Trim46ΔC chimeras (referred to as Trim46-BirA*); panels b and c are shown at different scales.
Known AIS proteins are indicated in red. Proteins enriched and previously identified as candidate AIS proteins in the NF186-BirA* samples are indicated in
blue. The solid line is the least-squares fit of the biotinylated proteins while the dotted lines parallel to the least-squares fit line represent an arbitrary
minimum of ten PSMs confidence interval. d Venn-diagram illustrating the number of candidate AIS proteins identified in each proximity proteome. e
Comparison of the PSMs for each protein biotinylated by BirA*-Ndel1C and proteins identified using combined Trim46ΔC-BirA* and BirA*-Trim46ΔC
chimeras. Known AIS proteins are indicated in red. Proteins enriched and previously identified as candidate AIS proteins in the NF186-BirA* samples are
indicated in blue. The solid line is the least-squares fit of the biotinylated proteins while the dotted lines parallel to the least-squares fit line represent an
arbitrary minimum of ten PSMs confidence interval. f–i Immunostaining of DIV14 cultured hippocampal neurons using antibodies against AnkG (red),
Tuba1a (f, green), Tuba4a (g, green), Tubb3 (h, green), Tubb5 (i, green), and Map2 (blue). The lower panels show the Triton X-100 detergent-resistant
pools of the indicated tubulins. AIS are indicated by arrowheads. Scalebars= 10 µm.
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Millipore Sigma Cat# MABN1153), rabbit polyclonal antibody anti-Septin 5 (1:200;
IBL-America Cat# 018921, RRID:AB_1540782), rabbit polyclonal antibody anti-
Septin 6 (1:500; Santa Cruz Biotechnology Cat# sc-20180, RRID:AB_2184999),
rabbit polyclonal antibody anti-Septin 7 (1:200; IBL-America Cat# JP18991, RRID:
AB_1630825), rabbit polyclonal antibody anti-Septin 11 (1:200; Millipore Sigma
Cat# ABN1342), mouse monoclonal antibody anti-FLAG (1:500; Millipore Sigma
Cat# F1804, RRIB:AB_262044), mouse monoclonal antibody anti-c-Myc (1:1000;
BioLegend, Cat# 626802, RRID:AB_2148451), mouse monoclonal antibody anti-
HA (1:1000; BioLegend Cat# 901503, RRID:AB_2565005), rabbit polycolonal
antibody anti-β4-spectrin (1:500; RRID:AB_2315634) was generated against the
peptide sequence DRAEELPRRRRPERQE (in the C-terminal “specific domain” of
β4 spectrin), mouse monoclonal antibody anti-β2-spectrin (1:1000; B&D Systems
Cat# 612563, RRID:AB_399854), mouse monoclonal antibody anti-α2-spectrin
(1:1000; BioLegend Cat# 803201, RRID:AB_2564660). Mouse monoclonal anti-
AnkyrinG (1:500; Cat# N106/36, RRID:AB_10673030 and N106/65, RRID:
AB_10675130), anti-Neurofascin (1:500; A12/18, AB_2282826), and anti-GST
(1:2000; N100/13, AB_10671818) antibodies were purchased from the UC Davis/
NIH NeuroMab Facility (Davis, CA). Rabbit polyclonal antibody anti-GFP (1:700;
Thermo Fisher Scientific, Cat# A-11122, RRID:AB_221569), mouse monoclonal
antibody anti-Klc1 (1:500; Santa Cruz Biotechnology Cat# sc-25735, RRID:
AB_2280879), mouse monoclonal antibody anti-Kif5A (1:1000; Santa Cruz Bio-
technology Cat# sc-376452, RRID:AB_11150294), rabbit polyclonal antibody anti-
Macf1 (1:200; Santa Cruz Biotechnology Cat# sc-68428, RRID:AB_2139238), rabbit
polyclonal antibody anti-Ranbp2 (1:200; Bethyl Cat# A301-796A, RRID:
AB_1211503), rabbit anti-Mical3 (1:200; a gift from Dr. Anna Akhmanova, Utrecht
University), mouse monoclonal antibody anti-Mical3 (1:500; a gift from Dr. Alex
Kolodkin, Johns Hopkins University), mouse monoclonal antibody anti-Map6
(1:400; Cell Signaling Technology Cat# 4265, RRID:AB_2140993), mouse mono-
clonal antibody anti-Tuba1a (1:1000; Millipore Sigma Cat# SAB1411824), rabbit
monoclonal antibody anti-Tuba4a (1:1000; abcam Cat# EPR13477(B)), mouse
monoclonal antibody to Tubb3 (1:1000; Millipore Cat# MAB1637, RRID:
AB_2210524), mouse monoclonal antibody anti-Tubb5 (1:1000; Millipore Sigma,
Cat# SAB1305556), rabbit polyclonal antibody anti-GAPDH (1:2000; Millipore
Sigma Cat#G9545, RRID:AB_796208). Chicken antibodies to: MAP2 (1:1000;
EnCor, Cat#CACP-MAP2, RRID:AB_2138173) and Neurofascin (1:1000; R&D
Systems Cat#AF3235, RRID:AB_10890736). Aminomethylcoumarin (AMCA),
Alexa Fluor 488, and Alexa Fluor 594 conjugated secondary antibodies were
purchased from Thermo Fisher Scientific (all 1:1000). Anti-mouse horseradish
peroxidase (HRP)-labeled secondary antibody (1:1000; GE Healthcare, Cat#
NA9310V, RRID:AB_7721983) and anti-rabbit HRP antibody (1:1000; 111-035-
003, Jackson Laboratory; RRID:AB_2313567). Streptavidin, Alexa Fluor 488 and
594 conjugates were purchased from Thermo Fisher Scientific (1:2000; Cat#
S11223, RRID:AB_2336881 and S11227, RRID:AB_2313574).
Visualization of actin patches. For actin visualization, DIV 14 cells were fixed
with 4% paraformaldehyde pH= 7.5 for 10 min, then permeabilized for 1 h PBGTS
0.1% Triton, followed by 1 h of dye-loading with 100 nM Acti-stain 488 Fluor-
escent Phalloidin (Amanita phalloides) (Cytoskeleton, Inc, Denver, CO Cat#
PHDG1), Acti-stain 555 Fluorescent Phalloidin (Amanita phalloides) Cytoskeleton,
Inc, Denver, CO Cat# PHDH1), taken from a 14 μM stock prepared according to
the manufacturer’s instructions. Staining of neurons was done on all cultures at the
same time and with the same reagents for each experiment. To count actin patches,
experimenters were blinded to the plasmid transfection (except for the case of no
transfection since there was no red fluorescent protein (RFP) signal). Images of AIS
in neurons with RFP were then taken at 63×. The images were then randomized,
and the number of actin patches along each AIS were counted. Each punctum of
phalloidin fluorescence was counted as an actin patch.
Cell culture. Primary cultures of hippocampal neurons were obtained from E18
Sprague-Dawley rat embryos. Hippocampi were dissected and dissociated. Neurons
were then plated onto Poly-D-Lysine (Sigma) and laminin-coated glass coverslips
(Life Technologies) at a density of 4800 cells/cm2. Hippocampal neurons were
cultured in Neurobasal medium (Life Technologies) containing 1% Glutamax (Life
Technologies), 1% penicillin and streptomycin (Life Technologies), and 2%
B27 supplement (Life Technologies) in an incubator with 5% CO2. Transfection of
hippocampal neurons was performed using Lipofectamine 200053. Human
embryonic kidney (HEK293T) (Cat#CRL-3216, RRID:CVCL_0063) cells and
COS7 Cells (Cat#CRL-1651, RRID:CVCL_0224) were purchased from ATCC and
cultured on cell culture dishes at 37 °C in Dulbecco’s Modified Eagle Media
(DMEM) containing 10% heat-inactivated Fetal bovine serum (GE Healthcare),
50 units/ml penicillin, and 50 μg/ml streptomycin.
Plasmid transfection. HEK293T cells and COS7 cells were transfected with
plasmid DNA using Lipofectamine 3000 (Invitrogen) according to the manu-
facturer’s instructions. The media was replaced after 24 h of transfection. Primary
hippocampal neurons were transfected with Lipofectamine 2000 (Invitrogen). After
neurons were washed with neurobasal media three times, the media was replaced
after 5 h of transfection.
Immunoblotting and Immunoprecipitation. HEK293T cells were transfected with
plasmid DNA using the Lipofectamine 3000 transfection reagent. After 48 h of
transfection, cells were lysed in RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 0.5%
sodium deoxycholate, 0.1% SDS, and 1% NP-40) or lysis buffer (50 mM Tris-HCl
(pH8.0), 150 mM NaCl, 1 mM EDTA, 0.1% Triton X-100) and the lysates were
centrifuged at 13,000 × g for 10 min at 4 °C. Alternatively, brain homogenate was
lysed in RIPA buffer. Lysates were mixed with protein G resin (GE Healthcare)
preabsorbed with each of the primary antibodies. The immune complexes were
precipitated by centrifugation and washed three times with RIPA or lysis buffer.
The immunoprecipitants were boiled in sample buffer and then separated by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE). The
proteins in supernatants were denatured in Laemmli sample buffer and then
subjected to SDS-PAGE. The electrophoretically separated proteins were trans-
ferred to a polyvinylidene difluoride membrane, blocked with 5% skim milk, and
immunoblotted with each of the primary antibodies and in turn with peroxidase-
conjugated secondary antibodies. Original immunoblots used here are included in
the source data file.
For α2 spectrin GST fusion protein pulldowns, HEK293T cells were transfected
with plasmid DNA (Mical3-myc+ α2 spectrin GST fusion protein) using the
Lipofectamine 3000 transfection reagent. After 24 h of transfection, cells were lysed
in lysis buffer (150 mM NaCl, 20 mM Tris-HCl (ph8.0), 10 mM EDTA, and 1%
Triton X-100) and the lysates were centrifuged at 13,000 × g for 10 min at 4 °C.
Lysates were mixed with glutathione sepharose 4B beads (GE Healthcare)
preblocked in 10 mg/ml BSA overnight at 4 °C. Beads and depleted supernatants
were boiled in reducing sample buffer and proteins were separated by SDS-PAGE.
The electrophoretically separated proteins were transferred to nitrocellulose
membranes and blocked with 5% skim milk. Membranes were immunoblotted
with mouse anti-myc or mouse anti-GST primary antibodies, followed by HRP-
conjugated goat anti-mouse secondary antibodies.
In vitro biotinylation. Cultured rat primary neurons (≅ 20 × 106 primary hippo-
campal neurons for each virus used) were transduced using the following adeno-
viruses; Ad-hENO2-HA-NF186-Myc-BirA*, Ad-hENO2-HA-NF186ΔFIGQY-Myc-
BirA*, Ad-hENO2-Ndel1C-Myc-BirA*, Ad-hENO2-Myc-BirA*-Ndel1C, Ad-
hENO2-Trim46ΔC -Myc-BirA*, and Ad-hENO2-Myc-BirA*-Trim46ΔC at DIV11
with titer concentration 7 MOI for each virus. Biotin was added at DIV13 at a final
concentration of 50 μM (Millipore Sigma Cat# B4639). Cells were collected at DIV14
and were lysed in RIPA buffer (50mM Tris-HCl, 150mM NaCl, 0.5% sodium
deoxycholate, 0.1% SDS, and 1% NP-40). Biotinylated proteins were isolated using
Streptavidin magnetic sepharose beads (GE Healthcare) overnight at 4 °C and then
beads washed three times in 50mM Tris buffered saline pH= 7.5.
Mass spectrometry. Sample-incubated streptavidin magnetic sepharose beads were
resuspended in 5mMDTT in 100mMNH4HCO3 and incubated for 30min at room
temperature. After this, iodoacetamide was added to a final concentration of 7.5 mM
and samples incubated for 30 additional minutes. In all, 0.5 μg of sequencing grade
trypsin (Promega) was added to each sample and incubated at 37 °C overnight.
Supernatants of the beads were recovered, and beads digested again using 0.5 μg
trypsin in 100mM NH4HCO3 for 2 h. Peptides from both consecutive digestions
were recovered by solid phase extraction using C18 ZipTips (Millipore), and
resuspended in 0.1% formic acid for analysis by liquid chromatography–mass
spectrometry (LC-MS/MS). Peptides resulting from trypsinization were analyzed on
a QExactive Plus (Thermo Scientific), connected to a NanoAcquity™ Ultra Perfor-
mance UPLC system (Waters). A 15-cm EasySpray C18 column (Thermo Scientific)
was used to resolve peptides (90-min gradient with 0.1% formic acid in water as
mobile phase A and 0.1% formic acid in acetonitrile as mobile phase B). MS was
operated in data-dependent mode to automatically switch between MS and MS/MS.
The top ten precursor ions with a charge state of 2+ or higher were fragmented by
high-energy collisional dissociation. Peak lists were generated using PAVA soft-
ware66. All generated peak lists were searched against the rat subset of the UniProt
database (UniprotKB 2017.11.01) using Protein Prospector67. The database search
was performed with the following parameters: a mass tolerance of 20 ppm for pre-
cursor masses; 30 ppm for MS/MS, cysteine carbamidomethylation as a fixed
modification and acetylation of the N terminus of the protein, pyroglutamate for-
mation from N-terminal glutamine, and oxidation of methionine as variable mod-
ifications. All spectra identified as matches to peptides of a given protein were
reported, and the number of spectra (Peptide Spectral Matches, PSMs) used for label
free quantitation of protein abundance in the samples.
Protein networks analysis. The networks was constructed in Cytoscape using the
STRING protein interaction database for mus musculus. Proteins were included if
their fold change was >2 and at least ten peptides were found in one dataset.
Interactions with a confidence score above 0.40 were included. Black line thickness
was mapped to STRING interaction score and node size was set to the logarithm of
the fold change. The size of the “Nfasc” node and node colors were manually set for
esthetic purposes.
Immunofluorescence microscopy. Cultured rat primary neurons were fixed in 4%
paraformaldehyde (PFA, pH7.2) and immunostained with the indicated antibodies.
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In some instances, neurons were “extracted” prior to fixation using 0.5% TX-100
for 5 min at room temperature, or for 15 min at 4 °C. Images of immuno-
fluorescence were captured using an Axio-imager Z1 microscope (Carl Zeiss
MicroImaging) or Axio-observer Z1 microscope (Carl Zeiss MicroImaging) fitted
with an AxioCam digital camera and Apotome for structured illumination (Carl
Zeiss MicroImaging). Images were taken and collected by Zen (Carl Zeiss
MicroImaging) acquisition software.
Immunofluorescence analysis of AIS. After immunolabeling, we grouped
shRNA-treated neurons according to whether they had an AIS, no AIS, or a
disrupted AIS. “No AIS” included only neurons lacking AnkG in any processes. In
some instances, AIS appeared fragmented or had dramatically reduced amounts of
AIS AnkG compared to untransfected control neurons in the same dish. We
counted these, pooled these with neurons lacking AIS, and considered them “no/
disrupted AIS”. Experimenters were blinded to the experimental condition. For
detergent extraction experiments, we subjectively determined if immuno-
fluorescence for a candidate was above background and colocalized with AnkG.
Single-molecule localization microscopy. Fourteen days in vitro (DIV) neurons
were fixed using 4% PFA in PEM (80 mM Pipes, 5 mM EGTA, and 2 mM MgCl2,
pH 6.8) for 10 min. After blocking, they were incubated with primary antibodies
overnight at 4 °C, then with DNA-PAINT secondary antibodies (Ultivue) for 1 h at
room temperature. DNA-PAINT imaging was performed on an N-STORM
microscope (Nikon Instruments). The two channels were imaged sequentially in
imaging buffer (PBS, 500 mM NaCl, 5% dextran sulfate) using the 647 nm laser at
40–60% power for 40,000 frames at 20 Hz. The first channel imaged was Mical3
with 0.26 nM imager I2-650, then α2-spectrin with 0.125 nM imager I1-650
(imagers from Ultivue).
Statistics, reproducibility, and data presentation. All statistics were performed
using Excel or GraphPad Prism software. Statistical tests are stated in each figure
legend. Plots of mass spectrometry results were generated using R programming
language. For all experiments involving immunofluorescence imaging, at least
three independent experiments were performed with similar results; repre-
sentative images are shown. The only exception to this was the SMLM of Mical3
where one independent experiment was performed. Nevertheless, many cells in
this experiment were imaged with similar results. For immunoblots, the number
of times each experiment was repeated varied from 1 to 3. For the blots shown in
Figs. 3f and 4g, n= 1; for the blots shown in Fig. 5c and S4f, n= 2 experiments
with similar results; for the blots shown in Figs. 3d, e and S4b, n= 3 experiments
with similar results.
Data availability
All data generated or analyzed during this study, including mass spectrometry data sets,
are available from the corresponding author upon request. All proteomics data have been
deposited to the ProteomeXchange Consortium via the PRIDE partner repository with
the dataset identifier PXD016272. A supplemental file including all PSMs is provided in
Supplementary Data 1. The source data underlying Figs. 3d–f, 4b, d, g, 5g, 6b, d, i, j, and
S4b, d, f, h are provided in the Source Data file.
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